Heart failure therapy at a crossroad: are there limits to the neurohormonal model?
Authors:
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart FailureCirculation, 2002
- CHF: circulatory homeostasis gone awry.Congestive Heart Failure, 2002
- Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failureJACC, 2002
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001European Journal of Heart Failure, 2001
- Pathophysiology of chronic heart failureThe American Journal of Medicine, 2001
- Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter studyJACC, 2000
- Neurohumoral Blockade in CHF ManagementJournal of the Renin-Angiotensin-Aldosterone System, 2000
- Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart FailureCirculation, 1999
- The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptidesBritish Journal of Clinical Pharmacology, 1997